Insights On Outsourced Drug Development

  1. Designing The Human Emulation System 4/9/2024

    Examine how the Human Emulation System merges cutting-edge Organ-on-a-Chip technology with user-friendly design, paving the way for seamless experimentation and deeper insights into human biology.

  2. Multiplex Imaging 3/24/2025

    Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.

  3. Inside Asymchem's Advanced R&D Capabilities In The UK 2/12/2026

    Advanced experimentation, unified workflows, and continuous manufacturing are accelerating small‑molecule development, improving insight and creating more efficient paths from discovery to scale.

  4. Modified Release Formulations: Extending Drug Commercial Lifecycle 3/1/2024

    A CDMO with expertise in modified-release dosage forms can provide valuable assistance in formulation development, processing considerations, analytical challenges, and regulatory requirements.

  5. Cell Cycle Mapping In Tumors With Advanced Technologies 9/2/2025

    Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.

  6. Microglia: Where We Came From And Where We Are Now 10/8/2024

    Gain expert insights into the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.

  7. Boosting In Vitro Toxicology Testing With Organ-Chips 4/9/2024

    Discover how Organ-Chips are enhancing preclinical testing, minimizing toxicity issues, and streamlining clinical trials for enhanced safety and efficiency.

  8. Formulation Development For Therapeutic Oligonucleotides 6/10/2025

    Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.

  9. Advanced Therapies Going Mainstream: Are We There Yet? 11/14/2025

    Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.

  10. New And Upcoming Trends In Immunodiagnostics 7/15/2024

    Explore the latest trends and cutting-edge technologies in immunodiagnostics that are transforming disease detection.